Bosh sahifaDNA • NYSE
add
Ginkgo Bioworks Holdings Inc
15,83 $
Seans yopilganidan keyin:(1,26%)-0,20
15,63 $
Yopilgan:15-okt, 18:51:32 (GMT-4) · USD · NYSE · Ogohlantirish
Yopilish kursi
14,09 $
Kunlik diapazon
14,26 $ - 16,09 $
Yillik diapazon
5,00 $ - 17,58 $
Bozor kapitalizatsiyasi
889,64 mln USD
Oʻrtacha hajm
1,70 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NYSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 49,60 mln | -11,75% |
Joriy xarajat | 96,65 mln | -51,80% |
Sof foyda | -60,30 mln | 72,24% |
Sof foyda marjasi | -121,56 | 68,54% |
Har bir ulushga tushum | — | — |
EBITDA | -46,07 mln | 67,25% |
Amaldagi soliq stavkasi | 0,47% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 473,69 mln | -35,14% |
Jami aktivlari | 1,23 mlrd | -24,26% |
Jami passivlari | 618,06 mln | -21,98% |
Umumiy kapital | 612,95 mln | — |
Tarqatilgan aksiyalar | 55,43 mln | — |
Narxi/balansdagi bahosi | 1,27 | — |
Aktivlardan daromad | -12,25% | — |
Kapitaldan daromad | -14,57% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -60,30 mln | 72,24% |
Operatsiyalardan naqd pul | -40,25 mln | 52,30% |
Sarmoyadan naqd pul | -63,89 mln | -138,02% |
Moliyadan naqd pul | -98,00 ming | 56,64% |
Naqd pulning sof oʻzgarishi | -104,05 mln | 6,66% |
Boʻsh pul | -21,33 mln | 66,99% |
Haqida
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Wikipedia
CEO
Tashkil etilgan
2008
Sayt
Xodimlar soni
834
